4000 Healthcare Stakeholders Will Convene at ISPOR 2019

Conference Will Be Held May 18-22, 2019 in New Orleans, LA, USA With a Focus on a New Era in Health Economics and Outcomes Research


Lawrenceville, NJ, USA—May 13, 2019—ISPOR—the professional society for health economics and outcomes research (HEOR)—released the final program and speakers for its upcoming ISPOR 2019 annual conference scheduled for May 18-22, 2019 in New Orleans, LA, USA.

Read more ›
Posted in Announcements, ISPOR News & Press Tagged with: , ,

ISPOR Releases Annual Report Highlighting a Year of Milestones

Lawrenceville, NJ, USA—May 7, 2019—ISPOR—the professional society for health economics and outcomes research, today released its 2018 Annual Report. The report highlights a very productive year with Society achieving a number of notable milestones. The Society set new records, launched many new initiatives, and reinvested heavily in its mission.

Read more ›
Posted in Announcements, ISPOR News & Press Tagged with:

Report: Health Economics Outcomes are Rarely Considered in Adaptive Clinical Trial Designs

Opportunities Are Potentially Being Missed to Improve Healthcare Decision Making

Lawrenceville, NJ, USA—April 30, 2019—Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of new research showing that consideration is rarely given to the health economic analysis of adaptive clinical trials. As a result, opportunities to use health economic outcomes in the design and analysis of adaptive trials are being missed. The paper, “A Review of Clinical Trials With an Adaptive Design and Health Economic Analysis,” was published in the April 2019 issue of Value in Health

Read more ›
Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , ,

ISPOR Supports Advancement of HEOR Excellence in Low- and Middle-Income Countries

ANNOUNCEMENT

Society’s Initiatives Advance the Science as Part of Its Mission to Improve Healthcare Decision Making Globally

Lawrenceville, NJ, USA—April 29, 2019—ISPOR—the professional society for health economics and outcomes research (HEOR), is committed to the advancement of HEOR excellence in low- and middle-income countries (LMICs). The Society’s many initiatives for LMICs are an integral part of its mission to improve healthcare decision making to improve decision making for health globally.

In support of its mission, ISPOR committed US $2.9 million toward mission-critical initiatives in 2018 alone. The Society advances HEOR globally through its consortia, networks, and chapters and by producing worldwide conferences, training and education, and publications. It also sponsors travel grant programs for both professional and student members and low- and middle-income countries chapter funding programs. These activities help to advance the Society’s mission in emerging markets.

Read more ›
Posted in Announcements, ISPOR News & Press Tagged with: ,

Bayesian Networks: A Powerful and Flexible Tool for Analyzing Health Economics and Outcomes Research Data

Lawrenceville, NJ, USA—April 25, 2019—Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of a new report introducing Bayesian networks, a knowledge representation and machine-learning tool for risk estimation in medical science. The article discusses several challenges associated with traditional risk prediction methods and then describes Bayesian networks and their construction, application, and advantages in risk prediction based on examples in cancer and heart disease. The paper, “Bayesian Networks for Risk Prediction Using Real-World Data: A Tool for Precision Medicine,” was published in the April 2019 issue of Value in Health.

Read more ›
Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with:

Renowned Keynote and Plenary Speakers Will Debate Global Issues on the Future of HEOR at ISPOR 2019

Lawrenceville, NJ, USA—April 23, 2019—ISPOR—the professional society for health economics and outcomes research (HEOR), announced plenary sessions and speakers for its ISPOR 2019 annual, international conference. The conference will be held May 18-22, 2019 in New Orleans, LA, USA and will focus on the theme, “Rapid. Disruptive. Innovative: A New Era in HEOR.” Program co-chairs for ISPOR 2019 include Jalpa Doshi, PhD, University of Pennsylvania, Philadelphia, PA, USA; Brian O’Rourke, PharmD, Canadian Agency for Drugs and Technologies in Health, Ottawa, ON, Canada; and Rosanna Tarricone, PhD, MSc, Bocconi University, Milan, Italy.

Read more ›
Posted in Announcements, ISPOR News & Press Tagged with: , ,

ISPOR Announces 2019 Health Economics and Outcomes Research Awards

Lawrenceville, NJ, USA—April 15, 2019—ISPOR, the professional society for health economics and outcomes research (HEOR), announced today the honorees for its 2019 HEOR Scientific and Leadership Awards. ISPOR Scientific Awards are designed to foster and recognize excellence and outstanding technical achievement in HEOR and its Leadership Awards recognize excellence and outstanding leadership in the field. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: , , , , ,

Pharmaceutical Risk-Sharing Arrangements Can Reduce Drug Costs for Payers

Study in Non–Small Cell Lung Cancer Using Real-World Data

Lawrenceville, NJ, USA—March 25, 2019—Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of new research showing that pharmaceutical risk-sharing arrangements can mitigate uncertainty around the budget impact of drugs, but only when the type of arrangement matches the setting and type of uncertainty. The report, “Determining the Comparative Value of Pharmaceutical Risk-Sharing Policies in Non–Small Cell Lung Cancer Using Real-World Data,” was published in the March 2019 issue of Value in HealthRead more ›

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , ,

Canadian Public Places High Priority on Drugs’ Safety, Effectiveness, and Certainty of Evidence

Survey Reveals Top Values for Drug Coverage Decision Making

Lawrenceville, NJ, USA—March 25, 2019—Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of new research showing that Canadians believe drug coverage decision makers should prioritize safety, effectiveness, and strong evidence. The report, “Evaluating Canadians’ Values for Drug Coverage Decision Making,” was published in the March 2019 issue of Value in Health. Read more ›

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , ,